caffeine has been researched along with daunorubicin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Nakanishi, Y; Schneider, EL | 1 |
| Durie, EL; Pessah, IN; Schiedt, MJ; Zimanyi, I | 1 |
| Abramson, JJ; Buck, E; Casida, JE; Pessah, IN; Salama, G | 1 |
| Efferth, T; Fabry, U; Glatte, P; Osieka, R | 1 |
| Boucek, RJ; Cusack, BJ; Fill, M; Gambliel, HA; Li, X; Mushlin, PS; Olson, RD; Palade, P; Shadle, SE | 1 |
| Burke, BE; Cusack, BJ; Gambliel, HA; Mushlin, PS; Olson, RD; Olson, SJ | 1 |
| Czyz, A; Gwizdek-Wiśniewska, A; Ochociński, J; Piosik, J; Ulanowska, K; Wegrzyn, G | 1 |
| Davies, DB; Evstigneev, MP; Khomich, VV | 1 |
| Beckerman, R; Donner, AJ; Espinosa, JM; Manley, JL; Mattia, M; Peart, MJ; Prives, C | 1 |
1 review(s) available for caffeine and daunorubicin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for caffeine and daunorubicin
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vivo sister-chromatid exchange: a sensitive measure of DNA damage.
Topics: 4-Nitroquinoline-1-oxide; Animals; Bromodeoxyuridine; Caffeine; Chromosomes; Crossing Over, Genetic; Cytarabine; Daunorubicin; DNA; Drug Evaluation, Preclinical; Ethyl Methanesulfonate; Genetic Techniques; Male; Methylnitronitrosoguanidine; Mice; Mice, Inbred C57BL; Mitomycins; Mutagens; X-Rays | 1979 |
Anthraquinone-sensitized Ca2+ release channel from rat cardiac sarcoplasmic reticulum: possible receptor-mediated mechanism of doxorubicin cardiomyopathy.
Topics: Alkaloids; Animals; Anthraquinones; Binding, Competitive; Caffeine; Calcium; Calcium Channels; Cardiomyopathies; Daunorubicin; Doxorubicin; Drug Interactions; Electrophoresis, Polyacrylamide Gel; Female; Heart; Kinetics; Male; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Structure-Activity Relationship | 1990 |
Mechanism of anthraquinone-induced calcium release from skeletal muscle sarcoplasmic reticulum.
Topics: Adenosine Triphosphate; Animals; Anthraquinones; Binding Sites; Caffeine; Calcium; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Magnesium; Mathematics; Mitoxantrone; Muscle Contraction; Muscles; Rabbits; Ryanodine; Sarcoplasmic Reticulum | 1988 |
Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells.
Topics: Apoptosis; Caffeine; Carboplatin; Cluster Analysis; Coloring Agents; Daunorubicin; Drug Resistance, Neoplasm; Flow Cytometry; G2 Phase; Gamma Rays; Gene Expression Regulation, Leukemic; Glutathione; GTP-Binding Proteins; HL-60 Cells; Humans; Immunohistochemistry; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Lymphoma, Non-Hodgkin; Multivariate Analysis; Oncogene Proteins v-fos; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; ras Proteins; S Phase; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1995 |
Sarcoplasmic reticulum calcium release is stimulated and inhibited by daunorubicin and daunorubicinol.
Topics: Animals; Antibiotics, Antineoplastic; Caffeine; Calcium; Daunorubicin; Dithiothreitol; Dogs; Female; In Vitro Techniques; Male; Microsomes; Sarcoplasmic Reticulum; Sulfhydryl Reagents | 2000 |
Decreased sensitivity of neonatal rabbit sarcoplasmic reticulum to anthracycline cardiotoxicity.
Topics: Aging; Animals; Animals, Newborn; Antibiotics, Antineoplastic; Caffeine; Daunorubicin; Doxorubicin; Female; Heart Atria; Heart Diseases; Male; Muscle Relaxation; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Rabbits; Sarcoplasmic Reticulum | 2002 |
Methylxanthines (caffeine, pentoxifylline and theophylline) decrease the mutagenic effect of daunomycin, doxorubicin and mitoxantrone.
Topics: Antimutagenic Agents; Caffeine; Cell Survival; Daunorubicin; Doxorubicin; Mitoxantrone; Mutagenicity Tests; Pentoxifylline; Structure-Activity Relationship; Theophylline; Vibrio; Xanthenes | 2005 |
Complexation of anthracycline drugs with DNA in the presence of caffeine.
Topics: Anthracyclines; Anti-Bacterial Agents; Binding, Competitive; Buffers; Caffeine; Central Nervous System Stimulants; Daunorubicin; DNA; Doxorubicin; Drug Synergism; Magnetic Resonance Spectroscopy; Models, Chemical; Models, Statistical; Nogalamycin; Temperature | 2006 |
A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint.
Topics: Ataxia Telangiectasia Mutated Proteins; Caffeine; Cell Cycle Proteins; Checkpoint Kinase 1; Checkpoint Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Daunorubicin; DNA Replication; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Hydroxyurea; Nucleic Acid Synthesis Inhibitors; Promoter Regions, Genetic; Protein Kinases; Protein Serine-Threonine Kinases; RNA, Messenger; S Phase; Signal Transduction; Transcription Factors; Tumor Suppressor Protein p53 | 2009 |